Abstract:Background Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epithelium. The aim of the study is to identify if any lncRNA might associate with inflammation or oxidative stress in CCA and regulate the disease progression. Methods In this study, RNA-seqs datasets were used to identify aberrantly expressed lncRNAs. Small interfering RNA and overexpressed plasmids were used to modulate the expression of lncRNAs, and luciferase target assay RNA immunoprecipitation (RIP) was performed to explore the mechanism of miRNA-lncRNA sponging. Results We firstly analyzed five available RNA-seqs datasets to investigate aberrantly expressed lncRNAs which might associate with inflammation or oxidative stress. We identified that two lncRNAs, H19 and HULC, were differentially expressed among all the samples under the treatment of hypoxic or inflammatory factors, and they were shown to be stimulated by short-term oxidative stress responses to H 2 O 2 and glucose oxidase in CCA cell lines. Further studies revealed that these two lncRNAs promoted cholangiocyte migration and invasion via the inflammation pathway. H19 and HULC functioned as competing endogenous RNAs (ceRNAs) by sponging let-7a/let-7b and miR-372/miR-373, respectively, which activate pivotal inflammation cytokine IL-6 and chemokine receptor CXCR4. Conclusions Our study revealed that H19 and HULC, up-regulated by oxidative stress, regulate CCA cell migration and invasion by targeting IL-6 and CXCR4 via ceRNA patterns of sponging let-7a/let-7b and miR-372/miR-373, respectively. The results suggest that these lncRNAs might be the chief culprits of CCA pathogenesis and progression. The study provides new insight into the mechanism linking lncRNA function with CCA and may serve as novel targets for the development of new countermeasures of CCA.

IRF4-induced Upregulation of Lncrna SOX2-OT Promotes Cell Proliferation and Metastasis in Cholangiocarcinoma by Regulating SOX2 and PI3K/AKT Signaling.

Dysregulation of KCNQ1OT1 Promotes Cholangiocarcinoma Progression Via Mir-140-5p/sox4 Axis.

Long Noncoding RNA SOX2OT Promotes the Proliferation of Pancreatic Cancer by Binding to FUS

MiR-155-5p suppresses SOX1 to promote proliferation of cholangiocarcinoma via RAF/MEK/ERK pathway

Oncostatin M Expression and TP53 Mutation Status Regulate Tumor-Infiltration of Immune Cells and Survival Outcomes in Cholangiocarcinoma.

SOX4 is associated with poor prognosis in cholangiocarcinoma.

Impact of Lncrna SOX9-AS1 Overexpression on the Prognosis and Progression of Intrahepatic Cholangiocarcinoma.

Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway

Enhanced Expression of Long Non-Coding Rna Sox2ot Promoted Cell Proliferation and Motility in Colorectal Cancer

Up-regulation of Long Non-Coding RNA Sox2ot Promotes Hepatocellular Carcinoma Cell Metastasis and Correlates with Poor Prognosis.

[LncRNA SOX2OT enhances 5-fluorouracil resistance of cholangiocarcinoma cells by promoting autophagy via up-regulating SIRT1 expression]

LINC00844 Suppresses Tumor Progression and Predicts Survival Outcomes Through Inhibiting Mir-19A-5p in Cholangiocarcinoma

LINC01714 Enhances Gemcitabine Sensitivity by Modulating FOXO3 Phosphorylation in Cholangiocarcinoma.

SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1

Overexpression of Long Non-Coding RNA SOX2OT Promotes Esophageal Squamous Cell Carcinoma Growth

Long Noncoding RNA Sox2 Overlapping Transcript (SOX2OT) Promotes Non-Small-cell Lung Cancer Migration and Invasion Via Sponging Microrna 132 (Mir-132)

LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner

Mir-184 Post-Transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular Carcinoma

LINC00630 promotes cholangiocarcinoma cell proliferation, migration and invasion by mediating the miR-199a/FGF7 axis

Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1

Lncrna SOX2-OT Regulates Laryngeal Cancer Cell Proliferation, Migration and Invasion and Induces Apoptosis by Suppressing Mir-654.